We are live on ! Find out more

461 hedge funds and large institutions have $13.5B invested in Incyte in 2018 Q3 according to their latest regulatory filings, with 57 funds opening new positions, 175 increasing their positions, 156 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 57 | Existing positions closed: 43

29% more funds holding in top 10

Funds holding in top 10: 79 (+2)

12% more repeat investments, than reductions

Existing positions increased: 175 | Existing positions reduced: 156

2% more funds holding

Funds holding: 452461 (+9)

3% more capital invested

Capital invested by funds: $13.2B → $13.5B (+$330M)

1.08% less ownership

Funds ownership: 93.08%91.99% (-1.1%)

19% less call options, than puts

Call options by funds: $174M | Put options by funds: $214M

Holders
461
Holders Change
+9
Holders Change %
+1.99%
% of All Funds
10.54%
Holding in Top 10
9
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+28.57%
% of All Funds
0.21%
New
57
Increased
175
Reduced
156
Closed
43
Calls
$174M
Puts
$214M
Net Calls
-$40.4M
Net Calls Change
+$22.3M
Name Holding Trade Value Shares
Change
Change in
Stake
BBA
1
Baker Bros. Advisors
New York
$2.37B +$18.9K +275 +0%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.27B +$8.28M +120,700 +0.7%
BlackRock
3
BlackRock
New York
$1.04B +$42.1M +613,119 +4%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$1.04B +$3.49M +50,912 +0.3%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$603M -$155M -2,261,619 -21%
State Street
6
State Street
Massachusetts
$539M +$21.2M +308,614 +4%
Capital International Investors
7
Capital International Investors
California
$523M -$34.9M -508,630 -6%
MCMC
8
Matrix Capital Management Company
New Hampshire
$319M
MNG
9
Manning & Napier Group
New York
$319M +$22.7M +330,895 +8%
Sands Capital Management
10
Sands Capital Management
Virginia
$313M -$17M -247,225 -5%
BB
11
BB Biotech
Switzerland
$263M +$3.43M +50,000 +1%
UBS AM
12
UBS AM
Illinois
$241M +$5.58M +81,236 +2%
Invesco
13
Invesco
Georgia
$215M +$6.54M +95,260 +3%
Norges Bank
14
Norges Bank
Norway
$158M -$10.1M -146,896 -6%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$151M +$3.52M +51,253 +2%
UBS Group
16
UBS Group
Switzerland
$135M -$179M -2,606,972 -57%
Northern Trust
17
Northern Trust
Illinois
$132M -$637K -9,275 -0.5%
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$129M +$3.77M +54,948 +3%
Goldman Sachs
19
Goldman Sachs
New York
$127M -$52.4M -763,265 -29%
O
20
OppenheimerFunds
New York
$122M +$122M +1,771,933 New
Citadel Advisors
21
Citadel Advisors
Florida
$111M -$18.8M -273,493 -14%
First Trust Advisors
22
First Trust Advisors
Illinois
$107M +$47.4M +691,111 +81%
Bank of New York Mellon
23
Bank of New York Mellon
New York
$90.8M -$1.01M -14,743 -1%
Royal Bank of Canada
24
Royal Bank of Canada
Ontario, Canada
$78.7M +$5.04M +73,470 +7%
CG
25
Carmignac Gestion
France
$75.4M -$323K -4,700 -0.4%

INCY Hedge Fund Activity: Q3 2018 in Review

461 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q3 2018, worth a combined $13.5B — up 2.5% from $13.2B a quarter earlier.

Buyers outnumbered sellers: 57 funds opened new INCY positions and 43 closed out — a net gain of 14 holders — while 175 added to existing stakes and 156 trimmed.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $122M. The largest seller was UBS Group, cutting an estimated $179M.

  • 461 institutional investors held Incyte (INCY) as of Q3 2018, up from 452 in Q2 2018.
  • Funds reported $13.5B of Incyte stock for Q3 2018, up 2.5% quarter-over-quarter.
  • 57 funds opened new Incyte positions in Q3 2018 and 43 closed out, a net change of +14 holders.
  • The largest Incyte buyer in Q3 2018 was OppenheimerFunds, an estimated $122M added.
  • The largest Incyte seller in Q3 2018 was UBS Group, an estimated $179M sold.

Based on aggregated 13F filings for Q3 2018.